Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

The latest addition to the pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy. In May 2024, the Tandem Mobi insulin pump with ...

Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

Diabetics who fly with an insulin pump could find themselves with lower-than-normal blood sugar levels, a new study sa ...

A series of case reports to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...